Contents
Download PDF
pdf Download XML
57 Views
14 Downloads
Share this article
Research Article | Volume 16 Issue 11 (November, 2026) | Pages 95 - 99
Time Course Of Left Ventricular Functional Recovery After Coronary Artery Bypass Grafting In Patients With Severe Lv Dysfunction: A Retrospective Echocardiographic Study
 ,
 ,
 ,
 ,
 ,
1
MBBS, MS, MCH TRAINEE, DEPARTMENT OF CARDIO-THORACIC AND VASCULAR SURGERY, SUPER-SPECIALTY BLOCK VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
2
MBBS, MS, MCH, PROFESSOR, DEPARTMENT OF CARDIO-THORACIC AND VASCULAR SURGERY, SUPER-SPECIALTY BLOCK VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
3
MBBS, MS, MCH, ASSOCIATE PROFESSOR, DEPARTMENT OF CARDIO-THORACIC AND VASCULAR SURGERY, SUPER-SPECIALTY BLOCK VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
4
MBBS, MS, MCH, DIRECTOR PROFESSOR AND HEAD, DEPARTMENT OF CARDIO-THORACIC AND VASCULAR SURGERY, SUPER-SPECIALTY BLOCK VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
5
MBBS, MD, DNB, PROFESSOR, DEPARTMENT OF CARDIAC ANAESTHESIA, SUPER-SPECIALTY BLOCK, VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
6
MBBS, MCH TRAINEE, DEPARTMENT OF CARDIO-THORACIC AND VASCULAR SURGERY, SUPER-SPECIALTY BLOCK VMMC AND SAFDARJUNG HOSPITAL, NEW DELHI.
Under a Creative Commons license
Open Access
Received
Oct. 1, 2026
Revised
Oct. 15, 2026
Accepted
Nov. 1, 2026
Published
Nov. 19, 2026
Abstract

Background: Patients with severe left ventricular (LV) dysfunction undergoing coronary artery bypass grafting (CABG) are considered high risk, and the reversibility of LV dysfunction following revascularization remains variable. Identification of the time course of functional recovery is crucial for patient selection and postoperative management. Objective: To assess the extent, pattern, and duration of reversibility of LV dysfunction following CABG in patients with severe LV dysfunction using serial 2D echocardiographic evaluation. Method: This retrospective observational study included 35 patients with severe left ventricular dysfunction undergoing CABG. Serial 2D echocardiographic data were abstracted preoperatively and at 3 months, 6 months, and 1 year postoperatively, where available. Results: Mean LVEF increased from 26.71 ± 2.56% preoperatively to 34.21 ± 7.07% at 1 year, an absolute mean increase of 7.50 percentage points. Mean LVESi decreased by 0.80 mm/m² at 6 months and 1.46 mm/m² at 1 year; mean LVEDi decreased by 0.9 mm/m² and 1.72 mm/m², respectively. NYHA functional class shifted toward less symptomatic classes at 1 year. During the first postoperative year, the study demonstrated progressive improvement in LV systolic function, reductions in BSA-indexed LV dimensions, and improvement in functional. Conclusion: CABG results in significant and sustained improvement in LV function and LV dimensions in patients with severe LV dysfunction, with maximum recovery occurring within the first year.

 

INTRODUCTION

Ischemic cardiomyopathy is a major cause of heart failure worldwide and is associated with high morbidity and mortality [1,17,18]. Patients with severe LV dysfunction represent a particularly challenging subgroup due to increased perioperative risk and uncertainty regarding postoperative recovery [1].

 

The concept of myocardial hibernation, described by Rahimtoola, explains chronic LV dysfunction secondary to persistent hypoperfusion that remains reversible after restoration of coronary blood flow [4,5]. Several studies have demonstrated improvement in LV function following surgical revascularization, particularly in patients with viable myocardium [6-8, 11-12, 14-16]. Use of IABP was reported in selected high-risk cases [8–10].

 

Large randomized trials such as the STICH trial demonstrated improved long-term survival and ventricular function in patients with ischemic cardiomyopathy undergoing CABG compared with optimal medical therapy [1, 2, 19-20]. However, data regarding the time course of reversibility of LV dysfunction remain limited. The present study aims to evaluate the sequential recovery of LV function and remodelling following CABG.

MATERIALS AND METHODS

Statistical Analysis

 

Study Design: Retrospective observational study.

 

Study Period: 4 years (2021-2025)

 

Study Area: Cardiothoracic and Vascular Surgery, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi.

 

Sample Size: 35

 

Inclusion Criteria:

  1. Adults aged ≥ 18 years.
  2. Diagnosed with ischemic heart disease with severe LV dysfunction (LVEF ≤ 30%) confirmed by echocardiography or cardiac MRI, PET-CT, dobutamine stress echocardiography (DSE)
  3. Scheduled for isolated coronary artery bypass grafting (CABG).

 

Exclusion Criteria:

  1. Concomitant valvular or congenital heart disease
  2. Previous cardiac surgery

 

All patients underwent:

  • Coronary angiography
  • Baseline 2D echocardiography
  • Myocardial viability assessment in selected cases

 

Surgical Technique

CABG was performed using off-pump or on-pump techniques based on patient risk profile and coronary anatomy. Use of IABP was recorded in selected high-risk cases.

 

STATISTICAL ANALYSIS: -

For statistical analysis, data were initially entered into a Microsoft Excel spreadsheet and then analyzed using SPSS (version 27.0; SPSS Inc., Chicago, IL, USA) and GraphPad Prism (version 5). Numerical variables were summarized using means and standard deviations, while Data were entered into Excel and analyzed using SPSS and GraphPad Prism. Numerical variables were summarized using means and standard deviations, while categorical variables were described with counts and percentages. Two-sample t-tests were used to compare independent groups, while paired t-tests accounted for correlations in paired data. Chi-square tests (including Fisher’s exact test for small sample sizes) were used for categorical data comparisons. P-values ≤ 0.05 were considered statistically significant.

 

RESULTS

The study included 35 patients who underwent isolated coronary artery bypass grafting (CABG) for coronary artery disease associated with severe left ventricular (LV) dysfunction. The mean age was 56.54 ± 9.17 years (range, 43–77 years). The cohort comprised 32 men (91.4%) and 3 women (8.6%). The mean body surface area (BSA) was 1.62 ± 0.15 m² (range, 1.37–1.90 m²). Diabetes mellitus and hypertension were each recorded in 20 patients (57.1%), while 12 patients (34.3%) had a history of smoking. Chronic kidney disease was present in 2 patients (5.7%). Acute kidney injury, medical renal disease, and a history of carotid artery stenting were each recorded in 1 patient (2.9%). One patient (2.9%) had no documented comorbidity (Table 1).

 

The mean preoperative LVEF was 26.71 ± 2.56%, increasing to 27.29 ± 7.48% at 3 months, 30.79 ± 6.85% at 6 months, and 34.21 ± 7.07% at 1 year. The corresponding absolute mean increases from baseline were 0.57, 4.07, and 7.50%, respectively (Table 2). Comparisons demonstrated no statistically significant difference at 3 months (p = 0.072). However, significant improvements were observed at 6 months (p = 0.0251) and 1 year (p < 0.012). These findings indicate that improvement in LV systolic function was more evident during intermediate and late postoperative follow-up than during the early postoperative period (Table 3).

 

The mean BSA-indexed LV end-systolic dimension (LVESi) decreased from 26.83 ± 4.23 mm/m² preoperatively to 26.02 ± 4.00 mm/m² at 6 months and 25.37 ± 3.81 mm/m² at 1 year. The mean reductions from baseline were 0.81 mm/m² at 6 months (p < 0.001) and 1.46 mm/m² at 1 year (p < 0.001). Both comparisons demonstrated statistically significant reductions in indexed LV end-systolic dimension (Table 4).

Similarly, mean BSA-indexed LV end-diastolic dimension (LVEDi) decreased from 33.65 ± 3.95 mm/m² preoperatively to 32.73 ± 3.94 mm/m² at 6 months and 31.93 ± 3.78 mm/m² at 1 year. The mean reductions were 0.91 mm/m² at 6 months (p < 0.001) and 1.72 mm/m² at 1 year (p < 0.001), demonstrating statistically significant reductions at both follow-up assessments (table 5). Preoperatively, 16 patients (45.7%) were in NYHA functional class II, 19 (54.3%) were in class III, and no patient in class I and IV. At 1-year follow-up, 25 patients (71.4%) had improved to class I, while 9 (25.7%) were in class II and 1 (2.9%) was in class III. No patients remained in class IV. Analysis demonstrated a statistically significant improvement in NYHA functional class (p < 0.0001), with no patient demonstrating deterioration in functional class.

 

Table 1: Baseline Demographic and Clinical Characteristics

Characteristic Value n (%) / range
Age, years 56.5 ± 9.2 Range: 43–77
Male sex 32 91.4%
Female sex 3 8.6%
Body surface area, m² 1.62 ± 0.15 Range: 1.37–1.90
Diabetes mellitus 20 57.1%
Hypertension 20 57.1%
Smoking recorded 12 34.3%
Chronic kidney disease 2 5.7%
Acute kidney injury 1 2.9%
Carotid artery stenting recorded 1 2.9%
No comorbidity recorded 1 2.9%
Medical renal disease 1 2.9%

 

Table 2: Mean LVEF at Different Time Points

Time point No. of patients Mean LVEF (%) ± SD Observed LVEF category range
Pre-operative 35 26.71 ± 2.56 20–30%
3 months 35 27.29 ± 7.48 15–55%
6 months 35 30.79 ± 6.85 20–55%
1 year 35 34.21 ± 7.07 20–55%

 

Table 3: Association Between Follow-up EF (3 Months, 6 Months and 1 Year) and Pre-operative EF

  Mean LVEF Change P-value
A. EF at 3 Months +0.57% 0.0727
B. LVEF at 6 Months +4.07% 0.0251
C. LVEF at 1 Year +7.50% 0.0120

 

Table 4: Comparison of Preoperative, 6 Months and 1 Year LVESi (Indexed to BSA)

Time point (LVESi)

Mean ± SD (mm/m²)

n

Observed range (mm/m²)

Mean change (mm/m²)

p-value

Pre-operative

26.83 ± 4.23

35

17.9–36.4

--

--

6 months

26..2 ± 4.00

35

17.9–35.5

-0.81

<0.001

1 year

25.37 ± 3.81

35

17.3–34.3

-1.46

<0.001

 

Table 5: Comparison of Preoperative, 6 Months and 1 Year LVEDi (Indexed to BSA)

Time point (LVEDi)

Mean ± SD (mm/m²)

n

Observed range (mm/m²)

Mean change (mm/m²)

p-value

Pre-operative

33.65 ± 3.95

35

25.0–40.0

---

---

6 months

32.73 ± 3.94

35

25.0–40.2

-0.91

<0.001

1 year

31.93 ± 3.78

35

23.9–40.0

-1.72

<0.001

 

Table 6: Distribution of NYHA Functional Class Pre-operatively and at 1-Year Follow-up (secondary outcome)

NYHA Functional Class Preoperative (n = 35) 1-Year Follow-up (n = 35) Statistical test
NYHA I 0 (0.0%) 25 (71.4%) Chi-square
NYHA II 16 (45.7%) 9 (25.7%) χ² = 38.6
NYHA III 19 (54.3%) 1 (2.9%) p < 0.0001
NYHA IV 0 (0.0%) 0 (0.0%)  
DISCUSSION

In this 35-patient retrospective cohort of patients with severe left ventricular (LV) dysfunction undergoing coronary artery bypass grafting (CABG), a significant improvement in LV systolic function and reduction in indexed LV dimensions were observed during the first postoperative year. The mean left ventricular ejection fraction (LVEF) increased from 26.71 ± 2.56% preoperatively to 34.21 ± 7.07% at one year, representing a mean improvement of 7.50 percentage points (p < 0.001). Furthermore, the mean LV end-systolic dimension index (LVESi) decreased by 0.80 mm/m² at six months and 1.46 mm/m² at one year, while the corresponding reduction in LV end-diastolic dimension index (LVEDi) was 0.90 mm/m² and 1.74 mm/m², respectively (p < 0.001 for each paired comparison). These findings suggest progressive improvement in LV systolic function and ventricular reverse remodelling following surgical revascularisation.

 

The clinical improvement was also reflected in the postoperative NYHA functional class distribution. At one-year follow-up, 25 patients (71.4%) were in NYHA class I, nine patients (25.7%) were in class II, and only one patient (2.9%) remained in class III, with no patients remaining in class IV. The statistically significant improvement in NYHA functional class observed in this study further reinforces the clinical benefit of CABG in patients with severe LV dysfunction. Similar improvements in functional status have been reported in major clinical trials and registries, including the STICH trial, where symptomatic improvement was associated with favourable changes in ventricular function and long-term clinical outcomes.[19] The improvement in functional status, together with favourable changes in LVEF and indexed LV dimensions, suggests an association between surgical revascularisation and subsequent clinical and echocardiographic recovery.

 

The role of surgical revascularisation in patients with severe LV dysfunction has been evaluated in several landmark studies. The STICH trial demonstrated a long-term survival benefit associated with CABG in appropriately selected patients with ischemic cardiomyopathy. The present findings further support the role of surgical revascularisation in this high-risk population, demonstrating significant improvement in LV systolic function, ventricular dimensions, and functional status during follow-up.[12], [20].

 

Preoperative assessment of myocardial viability is an important consideration when evaluating patients with severe LV dysfunction for revascularisation. In the present study, myocardial viability assessment was performed using different imaging modalities, including positron emission tomography-computed tomography (PET-CT), dobutamine stress echocardiography (DSE), and conventional two-dimensional echocardiography.[6], [12], The choice of imaging modality varied among patients, reflecting the retrospective nature of the study, involvement of multiple surgeons, and individual surgeon preferences regarding preoperative evaluation.

 

Previous studies have demonstrated the association between myocardial viability and functional recovery following revascularisation. Di Carli MF et al. reported that the presence of more than 18% hibernating myocardium was associated with favourable functional recovery following coronary revascularisation[11]. Similarly, Bax et al. demonstrated that the presence of more than four viable myocardial segments with regional wall motion abnormalities was associated with a greater likelihood of improvement in LV systolic function after revascularisation[12]. These observations emphasise the importance of identifying viable myocardium when evaluating patients with ischemic LV dysfunction for surgical intervention.

 

Several studies have evaluated different parameters for predicting LV functional recovery following CABG, including LV end-systolic volume index (LVESVi) and LV end-diastolic volume index (LVEDVi)[21]. Öztürk C et al. have also highlighted the potential role of LVEDP as a haemodynamic marker associated with postoperative LV functional recovery. Although these parameters provide valuable information regarding ventricular remodelling and haemodynamic status, our institutional protocol focused on serial assessment of LVEF, LVESi, and LVEDi, indexed to body surface area (BSA) and expressed in mm/m². This approach enabled longitudinal assessment of LV systolic function and ventricular dimensions following surgical revascularisation.

 

Concomitant mitral regurgitation (MR) is another important consideration in patients with ischemic cardiomyopathy and LV dilatation. In our cohort, 17 patients had mild MR and 15 patients had moderate MR preoperatively, whereas no patient had severe MR. At the end of one-year follow-up, among the 15 patients with available MR assessment, five patients had moderate MR and ten patients had mild MR. This favourable distribution suggests a possible improvement in MR severity following revascularisation. The reduction in MR severity may be related to improvement in LV geometry, papillary muscle alignment, and ventricular reverse remodelling, potentially contributing to improved LV systolic function and clinical status [9,11]. However, the study was not specifically designed to establish a causal relationship between reverse remodelling and improvement in MR. The exclusion of patients with severe MR also limits the applicability of these findings to patients with advanced ischemic mitral regurgitation.

 

Regarding the surgical strategy, all patients in our cohort received a left internal mammary artery (LIMA) graft to the left anterior descending (LAD) coronary artery territory. Additional conduits included reversed saphenous vein grafts (RSVGs), while radial artery grafts were used in selected patients. No patient underwent concomitant surgical ventricular reconstruction (SVR) as part of the index CABG procedure, in accordance with our institutional protocol. Therefore, the observed postoperative changes in LV function and ventricular dimensions primarily represent outcomes following surgical revascularisation without additional ventricular reconstruction procedures.

 

Overall, our findings are consistent with previous studies supporting the role of CABG in patients with severe ischemic LV dysfunction [13,19,20]. The significant improvement in LVEF, progressive reduction in indexed LV dimensions, and favourable shift in NYHA functional class collectively suggest that surgical revascularisation may be associated with meaningful functional recovery and reverse ventricular remodelling in appropriately selected patients.

 

LIMITATIONS

The present study has several limitations. First, its retrospective, single-centre design and relatively small sample size of 35 patients limit the generalisability of the findings. Second, preoperative myocardial viability assessment was not performed using a uniform imaging protocol. The choice of investigation, including PET-CT, DSE, or conventional two-dimensional echocardiography, depended on clinical circumstances and individual surgeon preferences. Consequently, myocardial viability assessment was not standardised across the study population, introducing potential variability in patient evaluation and selection. Surgical decision-making was also influenced by individual clinical judgement rather than a uniform objective viability assessment protocol.

 

Third, owing to the retrospective nature of the study, three-month follow-up echocardiographic data were not available for all patients, limiting the assessment of early postoperative changes. Furthermore, advanced imaging modalities such as cardiac magnetic resonance imaging (CMR) were not utilised. Nevertheless, serial two-dimensional echocardiography provided a practical and widely accepted method for longitudinal assessment of LV systolic function and dimensions.

 

Fourth, routine postoperative CT coronary angiography was not performed to assess graft patency. Consequently, the relationship between individual graft patency, completeness of revascularisation, and subsequent improvement in LVEF could not be objectively established. Therefore, the observed improvement in LV function cannot be attributed exclusively to the patency of individual bypass grafts.

 

Finally, patients with severe MR were not included in this cohort, and no patient underwent concomitant SVR. Therefore, the findings should be interpreted within the context of the specific patient population and surgical strategy evaluated in this study.

CONCLUSION

In this 35-patient cohort with severe LV dysfunction, CABG was followed by a significant increase in mean LVEF and progressive reductions in body-surface-area-indexed LV end-systolic and end-diastolic dimensions during the first postoperative year. A favourable shift in NYHA functional class was also observed, accompanied by a reduction in MR severity among patients with available one-year follow-up assessment. These findings support an association between surgical revascularisation and subsequent improvement in LV systolic function, ventricular reverse remodelling, and clinical functional status in appropriately selected patients with severe ischemic LV dysfunction.

REFERENCES

1.       Velazquez EJ, Lee KL, Jones RH, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616.

2.       Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374(16):1511–1520.

3.       Revived-BCIS2 Investigators. Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. 2022;387(14):1351–1360.

4.       Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117(1):211–221.

5.       Rahimtoola SH. Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine. Circulation. 1993;87(4):1344–1354.

6.       Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol. 2002;39(7):1151–1158.

7.       Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364(17):1617–1625.

8.       Yamaguchi A, Adachi H, Kawahito K, Murata S, Ino T. Coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg. 2001;71(4):1162–1167.

9.       Mickleborough LL, Maruyama H, Takagi Y, et al. Results of revascularization in patients with severe left ventricular dysfunction. Circulation. 1995;92(9 Suppl):II73–II79.

10.    Elefteriades JA, Morales DL, Gradel C, et al. Results of coronary artery bypass grafting by a single surgeon in patients with severe left ventricular dysfunction. Ann Thorac Surg. 1997;63(5):1331–1337.

11.    Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization. Circulation. 1995;92(12):3436–3444.

12.    Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction after revascularization in patients with chronic ischemic LV dysfunction: Relationship with myocardial viability. J Am Coll Cardiol. 1999;34(1):163–169.

13.    Cleland JGF, Pennell DJ, Ray SG, et al. Myocardial viability testing and outcome in ischemic heart failure. Eur J Heart Fail. 2002;4(3):331–336.

14.    Carluccio E, Biagioli P, Alunni G, et al. Improvement of left ventricular function after revascularization in patients with ischemic cardiomyopathy. Eur Heart J. 2009;30(6):695–703.

15.    White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76(1):44–51.

16.    Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction. Circulation. 1993;87(3):755–763.

17.    Gheorghiade M, Bonow RO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation. 1998;97(3):282–289.

18.    Braunwald E. Heart failure. JACC Heart Fail. 2013;1(1):1–20.

19.    Howlett JG, Stebbins A, Petrie MC, Jhund PS, Castelvecchio S, Cherniavsky A, Sueta CA, Roy A, Pina IL, Wurm R, Drazner MH. CABG improves outcomes in patients with ischemic cardiomyopathy: 10-year follow-up of the STICH trial. JACC: Heart Failure. 2019 Oct;7(10):878-87.

20.    Petrie MC, Jhund PS, She L, Adlbrecht C, Doenst T, Panza JA, Hill JA, Lee KL, Rouleau JL, Prior DL, Ali IS. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction: an analysis of the extended follow-up of the STICH trial (Surgical Treatment for Ischemic Heart Failure). Circulation. 2016 Nov 1;134(18):1314-24.

21.    Papestiev V, Jovev S, Sokarovski M, Risteski P, Andova V, Zdraveski V, et al. Georgievska-Ismail Lj. Changes of Left Ventricular Systolic Function in Patients Undergoing Coronary Artery Bypass Grafting. Open Access Maced J Med Sci. 2019.

22.    Öztürk C, Yavuz Ş. Effect of coronary artery bypass surgery on ventricular functions in patients with poor left ventricular function. The European Research Journal. 2019;5(3):502–9.

Recommended Articles
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.